Our unique study design focused on SLE and CTD subjects prone to complement depression to demonstrate that a low C3 level is associated with a significant risk for serious bacterial infection within 30 days in pediatric SLE/CTD patients adjusting for general immunosuppression level and lupus nephritis diagnosis. Here, C3 is linked to systemic lupus erythematosus.